25 May 2013
Keywords: fda, cardio, panel, firmly, rejects, bristol-myers, squibb
Article | 29 July 2002
Surprising many analysts, the US Food and Drug Administration'sCardiovascular and Renal Drugs Advisory Committee has voted five to one
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 July 2002
24 May 2013
© 2013 thepharmaletter.com